PT  - JOURNAL ARTICLE
AU  - Rabinowitz, Jonathan
AU  - Darawshi, Mahmoud
AU  - Burak, Nuriel
AU  - Boehm, Manfred
AU  - Dmitrieva, Natalia I
TI  - Risk for hypertension and heart failure linked to high normal serum sodium in electronic medical records
AID  - 10.1101/2024.07.05.24309996
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.05.24309996
4099  - http://medrxiv.org/content/early/2024/07/05/2024.07.05.24309996.short
4100  - http://medrxiv.org/content/early/2024/07/05/2024.07.05.24309996.full
AB  - Background Population aging is fueling an epidemic of age-related chronic diseases. Managing risk factors and lifestyle interventions have proven effective in disease prevention. Epidemiological studies have linked markers of poor hydration with higher risk of chronic diseases and premature mortality. Many individuals do not adhere to recommended hydration levels and could benefit from improved hydration habits. Our study evaluates the use of electronic medical records to confirm the relationship between inadequate hydration and the risk of chronic diseases, which may inform hydration-focused interventions in general healthcare.Methods We analyzed 20-year electronic medical records for 411,029 adults from Israel’s Leumit Healthcare Services. Hydration status was assessed using serum sodium and tonicity. We included adults without significant chronic diseases or water balance issues, defined as having normal serum sodium (135-146 mmol/l) and no diagnosis of diabetes. We used Cox proportional hazards models, adjusted for age, to assess the risk of developing hypertension and heart failure.Findings Our findings showed an increased risk of hypertension with elevated serum sodium levels: a 12% rise for the 140-142 mmol/l group and 30% for levels above 143 mmol/l (HR1.30, 95%CI:1.26-1.34). Tonicity over 287 mosmol/kg was associated with a 19% increased risk of hypertension (HR1.19, 95%CI:1.17-1.22). The risk of heart failure also increased, reaching 20% for sodium levels above 143 mmol/l (HR1.20,95%CI:1.12-1.29) and 16% for tonicity above 289 mosmol/kg (HR1.16, 95%CI: 1.10-1.22). The association between sodium and hypertension was observed across genders, while the risk of heart failure was more pronounced in females. Within the healthy Leumit cohort, 19% had serum sodium levels within the 143-146 mmol/l range, and 39% were in the 140-142 mmol/l range.Interpretation Data analysis from electronic medical records identified a link between serum sodium of 140 mmol/l and above and increased risk of hypertension and heart failure in the general Israeli population. Identifying individuals with high-normal sodium values in healthcare records could guide improvements in hydration habits, potentially leading to better health outcomes.Funding This work was funded by the Elie Wiesel Chair at Bar-Ilan University, Ramat Gan, Israel, held by the lead author, and by Intramural Research program of the National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by the Elie Wiesel Chair at Bar-Ilan University, Ramat Gan, Israel, held by the lead author, and by Intramural Research program of the National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval to get access to the deidentified dataset and conduct the current study was granted by the Leumit Helsinki Institutional Review Board (protocol LEU-0009-23).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript